期刊文献+

甘利欣治疗肝炎病毒性传染病患者的临床疗效评价 被引量:1

下载PDF
导出
摘要 目的对甘利欣(甘草酸二铵注射液)在肝炎病毒性传染病患者中的治疗效果进行评估、调查。方法 70例肝炎病毒性传染病患者,随机分为观察组和对照组,各35例。对照组采用常规方式进行治疗,观察组在对照组基础上联合甘利欣治疗。对比两组患者的治疗效果。结果观察组显著16例、有效17例、无效2例;对照组显著12例、有效14例、无效9例;观察组患者总有效率为94.3%,对照组患者总有效率为74.3%,观察组患者总有效率高于对照组,差异具有统计学意义(P<0.05)。两组不良反应发生率比较差异无统计学意义(P>0.05)。结论甘利欣在肝炎病毒性传染病患者中的治疗效果更为理想,值得推广。
作者 辛秀丽
出处 《中国现代药物应用》 2016年第17期156-157,共2页 Chinese Journal of Modern Drug Application
  • 相关文献

参考文献3

二级参考文献18

  • 1Chinese Society of Hepatology and Chinese Society of Infectious Diseases,Chinese Medical Association. 42 Dongsi Xidajie,Beijing 100710,China.慢性乙型肝炎防治指南[J].中华肝脏病杂志,2005,13(12):881-891. 被引量:1931
  • 2Nath NC, Rahman MA, Khan MR, et al. Serum hyaluronic Acid as a predictor of fibrosis in chronic hepatitis B and C virus infection[J]. Mymensingh MedJ, 2011, 20(4): 614.
  • 3Dakin H, Sherman M, Fung S, et al. Cost effectiveness of tenofovir disoproxil fumarate for the treatment of chronic hepatitis B from a canadian public payer perspective [ J ]. Pharmacoeconomics, 2011, 29(12) : 1075.
  • 4Abediankenari S, Ghasemi M, Nasehi MM, et al. Determination of trace elements in patients with chronic hepatitis B [J]. Aeta Med Iran, 2011, 49(10): 667.
  • 5Lok AS, McMahon B J; Practice Guidelines Committee, American Association for the Study of Liver Diseases (AASLD). Chronic hepatitis B: update of recommendations. Hepatology, 2004, 39: 857-861.
  • 6Liaw YF, Leung N, Guan R, et al. Asian-Pacific consensus statement on the management of chronic hepatitis B: an update. J Gastroenterol Hepatol, 2003, 18: 239-245.
  • 7Mangi A, Villani MR, Minerva N, et al. Efficacy of 5MU of interferon in combination with ribavirin for naive patients with chronic hepatitis C virus: a randomized controlled trial. J Hepatol, 2001,34: 441-446.
  • 8Berg T, Sarrazin C, Herrmann E, et al. Prediction of treatment outcome in patients with chronic hepatitis C: significance of baseline parameters and viral dynamics during therapy. Hepatology, 2003,37: 600-609.
  • 9Strader DB, Waright T, Thomas DL, et al. Diagnosis, management,and treatment of hepatitis C. Hepatology, 2004, 39: 1147-1171.
  • 10Gauthier J, Bourne EJ, Lutz MW, et al. Quantitation of hepatitis Bviremia and emergence of YMDD variants in patients with chronic hepatitis B treated with lamivudine. J Infect Dis, 1999, 180: 1757-1762.

共引文献143

同被引文献8

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部